Advances in Health, inc.

Houston, Texas 77030

0 studies enrolling now · 28 studies all time

What they study most

Amenorrhea, Anemia, Contraception, Cystitis, Interstitial, Diabetes, Endometriosis, Endometriosis-related Pain, HIV Infections, Leiomyomas, Low Back Pain, Meningococcal Vaccines, Overactive Bladder

Studies at this site

• Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia — Completed
• Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) — Completed
• Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain — Completed
• Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4) — Stopped early
• Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream) — Completed
• Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women — Completed
• A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome — Stopped early
• RN624 In Adult Patients With Chronic Low Back Pain — Completed
• A Study of Tanezumab in Adults With Chronic Low Back Pain — Completed
• A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis — Stopped early
• Long Term Safety Study of Tanezumab in Chronic Low Back Pain — Stopped early
• Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles — Completed
• Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003 — Completed
• A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17 — Completed
• A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine. — Completed
• Contraceptive Effectiveness and Safety of the SILCS Diaphragm — Completed
• Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS) — Completed
• A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed
• An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext — Stopped early
• Study to Evaluate Menses Induction in Women Administered Proellex — Stopped early
• Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids — Stopped early
• Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids — Stopped early
• Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids — Stopped early
• Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids — Stopped early
• Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids — Completed
• Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel — Completed
• Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma — Withdrawn before enrolling
• Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel — Completed